Marked increase of plasma acid stable/soluble trypsin inhibitor in hemodialysis patients.
The activity of acid stable/soluble trypsin inhibitor (ASTI) was found to be considerably elevated in the plasma of hemodialysis patients (80.3 +/- 24.6 U/ml; 21-fold higher than normal). The increased ASTI was a very acidic compound (pI = 1.66) with a molecular weight (Mr) of 55000 by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Immunological identity of the ASTI to urinary trypsin inhibitor was confirmed.